BiotechTube
Home/Persista Bio/Linda Tempelman
LT

Linda Tempelman

CEO, Cofounder

Persista Bio

Therapeutic Areas

Type 1 DiabetesMetabolic Disorders

Persista Bio Pipeline

DrugIndicationPhase
O2Line™ SystemType 1 DiabetesPre-clinical

Leadership Team at Persista Bio

MM
Minglin Ma
Cofounder, Professor at Cornell
JF
James Flanders
Cofounder Emeritus
View full Persista Bio profile